US Stock MarketDetailed Quotes

Ascendis Pharma A/S (ASND)

Watchlist
  • 205.830
  • -9.210-4.28%
Close Jan 16 16:00 ET
  • 205.830
  • 0.0000.00%
Post 20:01 ET
12.70BMarket Cap-46.41P/E (TTM)

Ascendis Pharma A/S (ASND) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
103.84%2.15M
88.03%-7.34M
85.91%-14.31M
34.48%-306.2M
-105.26%-87.18M
54.99%-56.13M
59.96%-61.31M
30.92%-101.58M
5.72%-467.36M
70.03%-42.47M
Net income from continuing operations
38.52%-60.99M
64.48%-38.86M
27.79%-94.63M
21.47%-378.08M
55.72%-38.47M
38.85%-99.2M
9.92%-109.38M
-18.14%-131.04M
17.45%-481.45M
58.11%-86.88M
Operating gains losses
71.79%7.5M
-23.02%4.1M
-565.89%-26.58M
8.53%19.97M
56.20%4.58M
-35.52%4.37M
-28.56%5.32M
357.13%5.71M
3.84%18.4M
-63.21%2.93M
Depreciation and amortization
-8.12%4.02M
-1.82%4.31M
1.52%4.55M
-6.33%17.71M
-10.09%4.48M
-7.78%4.37M
-5.53%4.39M
-1.52%4.48M
5.31%18.91M
7.33%4.98M
Deferred tax
254.26%3.62M
1,580.35%3.85M
-57.70%1.06M
-33.68%4.84M
-81.26%1.09M
58.29%1.02M
153.38%229K
93.37%2.51M
35.82%7.3M
8.24%5.79M
Other non cash items
1,688.16%60.08M
24.57%-22.85M
-70.24%14.53M
2,306.38%47.35M
-20.40%32.61M
-119.10%-3.78M
-12.14%-30.3M
235.94%48.82M
49.40%-2.15M
-11.10%40.97M
Change In working capital
-69.86%24.64M
-93.78%-44.03M
197.39%50.49M
-7.39%-107.16M
-651.79%-114.35M
440.14%81.75M
37.83%-22.72M
-116.00%-51.84M
-700.08%-99.79M
-587.30%-15.21M
-Change in receivables
-186.08%-24.91M
-318.68%-47.99M
968.62%98.03M
-261.90%-118.61M
-1,364.25%-124.8M
313.80%28.94M
-935.32%-11.46M
-17.46%-11.29M
-184.22%-32.77M
-56.18%-8.52M
-Change in inventory
109.49%1.35M
44.32%-10.31M
110.69%2.54M
-10.76%-86.68M
-52.41%-30.18M
32.90%-14.23M
-8.50%-18.52M
-17.70%-23.75M
-41.60%-78.26M
25.84%-19.8M
-Change in prepaid assets
19.18%5.07M
-122.18%-1.28M
-41.42%-5.52M
191.05%10.39M
182.51%4.27M
-34.95%4.26M
321.71%5.77M
61.64%-3.9M
-78.08%-11.41M
-310.37%-5.18M
-Change in payables and accrued expense
-0.98%-7.53M
79.90%15.21M
-114.28%-40.77M
659.36%26.97M
547.56%44.99M
-273.90%-7.46M
271.83%8.45M
-233.64%-19.03M
-92.27%3.55M
-142.93%-10.05M
-Change in other working capital
-27.89%50.66M
104.87%339K
-161.93%-3.79M
218.06%60.77M
-130.48%-8.64M
61,185.22%70.25M
35.77%-6.97M
254.72%6.13M
29.16%19.11M
597.00%28.34M
Cash from discontinued investing activities
Operating cash flow
103.84%2.15M
88.03%-7.34M
85.91%-14.31M
34.48%-306.2M
-105.26%-87.18M
54.99%-56.13M
59.96%-61.31M
30.92%-101.58M
5.72%-467.36M
70.03%-42.47M
Investing cash flow
Cash flow from continuing investing activities
89.46%-53K
-813.49%-4.34M
-109.83%-703K
-97.60%6.88M
-105.77%-384K
-102.26%-503K
-98.71%608K
-96.60%7.16M
364.06%286.47M
934.50%6.65M
Net PPE purchase and sale
89.46%-53K
-813.49%-4.34M
-253.27%-703K
80.05%-477K
-663.24%-383K
45.91%-503K
236.94%608K
81.66%-199K
51.74%-2.39M
101.80%68K
Net investment purchase and sale
--0
--0
--0
-97.45%7.35M
-100.02%-1K
--0
--0
-96.53%7.35M
333.17%288.87M
120.54%6.58M
Cash from discontinued investing activities
Investing cash flow
89.46%-53K
-813.49%-4.34M
-109.83%-703K
-97.60%6.88M
-105.77%-384K
-102.26%-503K
-98.71%608K
-96.60%7.16M
364.06%286.47M
934.50%6.65M
Financing cash flow
Cash flow from continuing financing activities
-90.92%38.85M
384.36%6.98M
-197.83%-18.02M
230.57%443.93M
101.44%87K
198.47%427.87M
-6.32%-2.46M
2,724.36%18.42M
-66.15%134.29M
-548.85%-6.06M
Net issuance payments of debt
-105.00%-6.57M
-94.57%-5.49M
-10.05%-3.07M
-2.40%122.79M
52.93%-2.95M
-4.24%131.35M
-12.04%-2.82M
-8.49%-2.79M
-74.68%125.82M
-251.94%-6.26M
Net common stock issuance
--0
--0
---17.4M
--309.91M
--19.29M
--290.62M
--0
--0
--0
--0
Proceeds from stock option exercised by employees
669.13%45.43M
3,315.89%12.47M
-34.77%13.83M
196.66%30.51M
50.35%3.03M
-4.65%5.91M
75.48%365K
1,036.60%21.21M
99.61%10.29M
-35.53%2.02M
Net other financing activities
--0
--0
---11.4M
-964.62%-19.29M
----
----
----
----
---1.81M
----
Cash from discontinued financing activities
Financing cash flow
-90.92%38.85M
384.36%6.98M
-197.83%-18.02M
230.57%443.93M
101.44%87K
198.47%427.87M
-6.32%-2.46M
2,724.36%18.42M
-66.15%134.29M
-548.85%-6.06M
Net cash flow
Beginning cash position
90.98%494.05M
61.73%517.92M
42.68%559.54M
-11.83%392.16M
41.75%625.52M
-34.38%258.7M
-36.12%320.24M
-11.83%392.16M
-0.34%444.77M
-27.46%441.27M
Current changes in cash
-88.97%40.95M
92.56%-4.7M
56.53%-33.04M
410.35%144.61M
-108.90%-87.47M
808.59%371.24M
41.78%-63.16M
-220.83%-76M
-25.28%-46.6M
70.33%-41.87M
Effect of exchange rate changes
192.56%4.09M
-1,289.76%-19.18M
-310.35%-8.58M
479.01%22.77M
397.39%21.5M
-171.46%-4.42M
13.44%1.61M
163.87%4.08M
-116.83%-6.01M
67.77%-7.23M
End cash Position
-13.82%539.09M
90.98%494.05M
61.73%517.92M
42.68%559.54M
42.68%559.54M
41.75%625.52M
-34.38%258.7M
-36.12%320.24M
-11.83%392.16M
-11.83%392.16M
Free cash flow
103.71%2.1M
81.06%-11.68M
85.25%-15.02M
34.52%-307.62M
-106.47%-87.56M
54.94%-56.63M
59.86%-61.65M
31.29%-101.78M
7.92%-469.8M
70.85%-42.41M
Currency Unit
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 103.84%2.15M88.03%-7.34M85.91%-14.31M34.48%-306.2M-105.26%-87.18M54.99%-56.13M59.96%-61.31M30.92%-101.58M5.72%-467.36M70.03%-42.47M
Net income from continuing operations 38.52%-60.99M64.48%-38.86M27.79%-94.63M21.47%-378.08M55.72%-38.47M38.85%-99.2M9.92%-109.38M-18.14%-131.04M17.45%-481.45M58.11%-86.88M
Operating gains losses 71.79%7.5M-23.02%4.1M-565.89%-26.58M8.53%19.97M56.20%4.58M-35.52%4.37M-28.56%5.32M357.13%5.71M3.84%18.4M-63.21%2.93M
Depreciation and amortization -8.12%4.02M-1.82%4.31M1.52%4.55M-6.33%17.71M-10.09%4.48M-7.78%4.37M-5.53%4.39M-1.52%4.48M5.31%18.91M7.33%4.98M
Deferred tax 254.26%3.62M1,580.35%3.85M-57.70%1.06M-33.68%4.84M-81.26%1.09M58.29%1.02M153.38%229K93.37%2.51M35.82%7.3M8.24%5.79M
Other non cash items 1,688.16%60.08M24.57%-22.85M-70.24%14.53M2,306.38%47.35M-20.40%32.61M-119.10%-3.78M-12.14%-30.3M235.94%48.82M49.40%-2.15M-11.10%40.97M
Change In working capital -69.86%24.64M-93.78%-44.03M197.39%50.49M-7.39%-107.16M-651.79%-114.35M440.14%81.75M37.83%-22.72M-116.00%-51.84M-700.08%-99.79M-587.30%-15.21M
-Change in receivables -186.08%-24.91M-318.68%-47.99M968.62%98.03M-261.90%-118.61M-1,364.25%-124.8M313.80%28.94M-935.32%-11.46M-17.46%-11.29M-184.22%-32.77M-56.18%-8.52M
-Change in inventory 109.49%1.35M44.32%-10.31M110.69%2.54M-10.76%-86.68M-52.41%-30.18M32.90%-14.23M-8.50%-18.52M-17.70%-23.75M-41.60%-78.26M25.84%-19.8M
-Change in prepaid assets 19.18%5.07M-122.18%-1.28M-41.42%-5.52M191.05%10.39M182.51%4.27M-34.95%4.26M321.71%5.77M61.64%-3.9M-78.08%-11.41M-310.37%-5.18M
-Change in payables and accrued expense -0.98%-7.53M79.90%15.21M-114.28%-40.77M659.36%26.97M547.56%44.99M-273.90%-7.46M271.83%8.45M-233.64%-19.03M-92.27%3.55M-142.93%-10.05M
-Change in other working capital -27.89%50.66M104.87%339K-161.93%-3.79M218.06%60.77M-130.48%-8.64M61,185.22%70.25M35.77%-6.97M254.72%6.13M29.16%19.11M597.00%28.34M
Cash from discontinued investing activities
Operating cash flow 103.84%2.15M88.03%-7.34M85.91%-14.31M34.48%-306.2M-105.26%-87.18M54.99%-56.13M59.96%-61.31M30.92%-101.58M5.72%-467.36M70.03%-42.47M
Investing cash flow
Cash flow from continuing investing activities 89.46%-53K-813.49%-4.34M-109.83%-703K-97.60%6.88M-105.77%-384K-102.26%-503K-98.71%608K-96.60%7.16M364.06%286.47M934.50%6.65M
Net PPE purchase and sale 89.46%-53K-813.49%-4.34M-253.27%-703K80.05%-477K-663.24%-383K45.91%-503K236.94%608K81.66%-199K51.74%-2.39M101.80%68K
Net investment purchase and sale --0--0--0-97.45%7.35M-100.02%-1K--0--0-96.53%7.35M333.17%288.87M120.54%6.58M
Cash from discontinued investing activities
Investing cash flow 89.46%-53K-813.49%-4.34M-109.83%-703K-97.60%6.88M-105.77%-384K-102.26%-503K-98.71%608K-96.60%7.16M364.06%286.47M934.50%6.65M
Financing cash flow
Cash flow from continuing financing activities -90.92%38.85M384.36%6.98M-197.83%-18.02M230.57%443.93M101.44%87K198.47%427.87M-6.32%-2.46M2,724.36%18.42M-66.15%134.29M-548.85%-6.06M
Net issuance payments of debt -105.00%-6.57M-94.57%-5.49M-10.05%-3.07M-2.40%122.79M52.93%-2.95M-4.24%131.35M-12.04%-2.82M-8.49%-2.79M-74.68%125.82M-251.94%-6.26M
Net common stock issuance --0--0---17.4M--309.91M--19.29M--290.62M--0--0--0--0
Proceeds from stock option exercised by employees 669.13%45.43M3,315.89%12.47M-34.77%13.83M196.66%30.51M50.35%3.03M-4.65%5.91M75.48%365K1,036.60%21.21M99.61%10.29M-35.53%2.02M
Net other financing activities --0--0---11.4M-964.62%-19.29M-------------------1.81M----
Cash from discontinued financing activities
Financing cash flow -90.92%38.85M384.36%6.98M-197.83%-18.02M230.57%443.93M101.44%87K198.47%427.87M-6.32%-2.46M2,724.36%18.42M-66.15%134.29M-548.85%-6.06M
Net cash flow
Beginning cash position 90.98%494.05M61.73%517.92M42.68%559.54M-11.83%392.16M41.75%625.52M-34.38%258.7M-36.12%320.24M-11.83%392.16M-0.34%444.77M-27.46%441.27M
Current changes in cash -88.97%40.95M92.56%-4.7M56.53%-33.04M410.35%144.61M-108.90%-87.47M808.59%371.24M41.78%-63.16M-220.83%-76M-25.28%-46.6M70.33%-41.87M
Effect of exchange rate changes 192.56%4.09M-1,289.76%-19.18M-310.35%-8.58M479.01%22.77M397.39%21.5M-171.46%-4.42M13.44%1.61M163.87%4.08M-116.83%-6.01M67.77%-7.23M
End cash Position -13.82%539.09M90.98%494.05M61.73%517.92M42.68%559.54M42.68%559.54M41.75%625.52M-34.38%258.7M-36.12%320.24M-11.83%392.16M-11.83%392.16M
Free cash flow 103.71%2.1M81.06%-11.68M85.25%-15.02M34.52%-307.62M-106.47%-87.56M54.94%-56.63M59.86%-61.65M31.29%-101.78M7.92%-469.8M70.85%-42.41M
Currency Unit EUREUREUREUREUREUREUREUREUREUR
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More